Left Bundle Branch Block (LBBB)
Left bundle branch block (LBBB) is a cardiac conduction abnormality characterized by delayed activation of the left ventricle due to impaired conduction through the left bundle branch, resulting in QRS prolongation >120 ms and dyssynchronous left ventricular contraction. 1
Diagnostic Criteria and ECG Features
LBBB is diagnosed based on specific ECG characteristics with high-level evidence:
- QRS duration >120 ms
- Monophasic notched or plateau-topped R waves in leads I, aVL, V5, and V6
- Slurred predominant S waves in the right precordial leads
- Absence of septal q waves in leads I, V5, and V6 (due to abnormal septal activation from right to left) 1, 2
Pathophysiology and Clinical Significance
LBBB causes immediate electrical and mechanical dyssynchrony of the left ventricle with several important consequences:
- Reduces left ventricular ejection fraction instantly (to approximately 55% in an otherwise normal heart)
- Causes regional differences in myocardial workload leading to asymmetric hypertrophy
- May lead to left ventricular dilatation over time
- Creates inefficient ventricular contraction patterns 3, 2
LBBB is generally associated with a poorer prognosis compared to normal intraventricular conduction or right bundle branch block. It often indicates underlying cardiac pathology rather than being a benign finding. 1, 2
Progression and Clinical Course
LBBB can lead to a progressive decline in cardiac function:
- Initially, patients may be asymptomatic due to the heart's functional redundancy
- Over time (ranging from days to decades), patients may develop heart failure symptoms
- Disease progression typically follows this pattern:
- Heart failure with preserved ejection fraction (HFpEF) ≥50%
- Heart failure with moderately reduced ejection fraction (HFmrEF) 35-50%
- Heart failure with reduced ejection fraction (HFrEF) ≤35% 3
Etiologies of LBBB
LBBB can result from:
- Underlying cardiomyopathy or heart disease
- Conduction system degeneration
- Aortic valve disease
- Following cardiac procedures
- In rare cases, it may occur in structurally normal hearts (as in painful LBBB syndrome) 4, 5
Clinical Management
Evaluation
- LBBB on ECG warrants further cardiac evaluation in all cases as it represents an independent risk factor for cardiovascular mortality 4
- Baseline 12-lead ECG is essential for patients undergoing elevated-risk surgeries 1
Diagnostic Testing
- Exercise stress testing should be avoided due to poor specificity (33%) and diagnostic accuracy (36-60%)
- Pharmacologic stress testing is preferred:
- Vasodilator stress (dipyridamole or adenosine) perfusion imaging has superior diagnostic accuracy (88-92%)
- Dobutamine stress echocardiography is also appropriate with diagnostic accuracy of 87% 1
Treatment Options
Treatment of underlying cardiac disease is essential
Cardiac Resynchronization Therapy (CRT) is strongly recommended (Level I evidence) for patients with:
Emerging treatment approaches:
Special Considerations
- LBBB masks ECG diagnosis of left ventricular hypertrophy
- LBBB interferes with ischemia detection on ECG
- Regular follow-up with clinical evaluation and ECG is recommended to detect progression of conduction disease or development of heart failure 1
- Some patients with LBBB and normal ventricular dimensions/function at rest may have abnormal exercise responses (termed "latent cardiomyopathy") 2